Dietary α-cyclodextrin reduces atherosclerosis and modifies gut flora in apolipoprotein E-deficient mice

Does Dietary Fatty Acid, Decanoic Acid, Prevent Polycystic Ovary Syndrome?

(2016) Chunming Guo   ENDOCRINOLOGY

Serum amyloid A1: Structure, function and gene polymorphism

(2016) Lei Sun et al.   GENE

The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome

(2016) Marta Kanabus et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids

(2016) Marcelo J. A. Amar et al.   Lipids in Health and Disease

Long-chain monounsaturated fatty acid-rich fish oil attenuates the development of atherosclerosis in mouse models

(2016) Zhi-Hong Yang et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling

(2015) Robert Caesar et al.   Cell Metabolism

Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response

(2015) Fabrizio Montecucco et al.   VASCULAR PHARMACOLOGY

Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity

(2014) Amandine Everard et al.   ISME Journal

The contributory role of gut microbiota in cardiovascular disease

(2014) W.H. Wilson Tang et al.   JOURNAL OF CLINICAL INVESTIGATION

Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFκB activation

(2014) E.C. Aguilar et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis

(2013) Robert A Koeth et al.   NATURE MEDICINE

Functional interactions between the gut microbiota and host metabolism

(2012) Valentina Tremaroli et al.   NATURE

Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms

(2012) Hua V. Lin et al.   PLoS One

Gut microbiome, obesity, and metabolic dysfunction

(2011) Herbert Tilg et al.   JOURNAL OF CLINICAL INVESTIGATION

Assessment of Cholesterol Absorption Inhibitors Nanostructured Aluminosilicate and Cholestyramine Using In Vitro Lipolysis Model

(2011) Pavel Gershkovich et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Unravelling the effects of the environment and host genotype on the gut microbiome

(2011) Aymé Spor et al.   NATURE REVIEWS MICROBIOLOGY

Metagenomic biomarker discovery and explanation

(2011) Nicola Segata et al.   GENOME BIOLOGY

Dietary Blueberries Attenuate Atherosclerosis in Apolipoprotein E-Deficient Mice by Upregulating Antioxidant Enzyme Expression

(2010) Xianli Wu et al.   JOURNAL OF NUTRITION

Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice

(2010) Evelyne M. Dewulf et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

QIIME allows analysis of high-throughput community sequencing data

(2010) J Gregory Caporaso et al.   NATURE METHODS

The Beneficial Effects α-Cyclodextrin on Blood Lipids and Weight Loss in Healthy Humans

(2010) Kevin B. Comerford et al.   Obesity

Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel

(2009) Xiao-dong Pan et al.   Journal of Zhejiang University-SCIENCE B

Activation of the AMP activated protein kinase by short-chain fatty acids is the main mechanism underlying the beneficial effect of a high fiber diet on the metabolic syndrome

(2009) Guo-Xin Hu et al.   MEDICAL HYPOTHESES

Dietary α-cyclodextrin lowers low-density lipoprotein cholesterol and alters plasma fatty acid profile in low-density lipoprotein receptor knockout mice on a high-fat diet

(2008) Elke Maria Wagner et al.   METABOLISM-CLINICAL AND EXPERIMENTAL